Navigation Links
Elsevier announces the 2008 supplement of Reproductive Health Matters
Date:12/2/2008

Amsterdam, 2 December 2008 - Elsevier announced today the publication of Reproductive Health Matters 2008 Supplement on the theme of "Second trimester abortion: women's health and public policy". Second trimester abortion raises complex issues regarding methods, values, stigma, the burden on providers of service delivery and the sometimes complicated reality of women's lives and decisions. This issue of Reproductive Health Matters grew out of a conference on second trimester abortion convened in London in 2007 by the International Consortium on Medical Abortion and attended by 90 expert clinicians and advocates from all over the world.

In many countries, legislation prohibits or restricts the grounds for second trimester abortions. Instead of preventing women from having abortions, these laws often force them to risk their lives doing so. There will always be women who need abortions after 12 weeks of pregnancy, but the numbers diminish greatly by 20 weeks, and become rare after 24 weeks.

Abortion-related deaths have been declining globally in the past three decades because many more countries now have safe, legal abortion. Methods have become substantially safer and simpler, more providers have been trained, and women with complications are more likely to seek and to receive medical help, even where abortion is still legally restricted.

This issue calls for the need for second trimester abortion to be met in a safe, timely and sympathetic manner In-depth, country-based research is needed, to bring out the facts on second trimester abortion, as evidence of why it should be treated as a legitimate form of women's health care and supported in public health policy. Papers in this supplement cover the law and safety of second trimester abortion; women's and providers' perspectives; policy, politics and values; moving from unsafe to safe service delivery; currently recommended methods; methods that should go out of use; and recommendations for advocacy and action from the ICMA conference.

Titles include:

  • A critical appraisal of laws on second trimester abortion
  • Reasons for second trimester abortions in England and Wales
  • A week in the life of an abortion doctor, Western Cape Province, South Africa
  • Decision-making after ultrasound diagnosis of fetal abnormality
  • Fetal pain: do we know enough to do the right thing?

Among papers on the law and safety of second trimester abortion; women's and providers' perspectives; policy, politics and values; service delivery; and recommended methods and methods that should go out of use. Other articles focus on countries such as Cuba, India, Mongolia, Mozambique, Nepal, the Netherlands, USA and Vietnam.


'/>"/>

Contact: Minke Havelaar
m.havelaar@elsevier.com
31-204-853-122
Elsevier
Source:Eurekalert

Related medicine news :

1. Elsevier launches new journal: Stem Cell Research
2. Elsevier announces new journal on inflammatory bowel diseases
3. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
4. Excerpta Medica and Elsevier Interactive Solutions merge into 1 integrated provider
5. Elsevier journals participate widely in global theme issue on poverty and human development
6. ScienceDirect to host French-language journals from Elsevier Masson
7. Elseviers "WiserWiki" Allows Physicians to Update Evidence-Based Medical Information With Experience-Based Practice Insights
8. Elseviers WiserWiki allows physicians to update evidence-based medical information
9. Elsevier Foundation Announces Grants for Innovative Libraries and New Scholars
10. Elsevier Foundation announces grants for innovative libraries and new scholars
11. Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Cranbury, NJ (PRWEB) , ... February 23, 2017 ... ... disease media outlet with a clinician-based audience, will be participating in Rare Disease ... 2017, in Washington, D.C. In addition, Rare Disease Report, a website, weekly e-newsletter ...
(Date:2/23/2017)... ... ... Hamlin Dental Group and Dr. Hamid Reza, dentist in North Hollywood ... of February, patients who visit Hamlin Dental Group will receive a ticket for a ... the Cheesecake Factory. , Tickets are available for routine dental visits and other ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... will host a diverse symposium on “Doping in Sport: How the ... Sheppard Mullin Richter & Hampton LLP. The symposium will be held at Pepperdine ...
(Date:2/23/2017)... ... 2017 , ... ERT, a global data and technology company ... a leading clinical development service provider, has selected ERT’s Trial Oversight suite as ... part to an array of circumstances including the use of multiple data capture ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center for Autism ... Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly ... (ASD) to see films in an environment that accommodates their unique needs. , ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 24 février 2017 ITL Limited, ( ASX : ITD ), ... ravie d,annoncer les excellents résultats semestriels clos le 31 ... Une présentation complète « Résultats et mise à jour sur ... . Faits marquants ... 1,04 million $ ; en hausse de 104 %) ...
(Date:2/24/2017)... 24, 2017 Medivir AB (Nasdaq ... a new Board of Directors that will be submitted ... Committee comprises representatives of the company,s three largest shareholders ... who have accepted a seat on the Nomination Committee, ... the 2016-2017 Nomination Committee was as follows:  ...
(Date:2/23/2017)...  Genesis Healthcare Services has merged with Hospice Cloud, ... Bill Monast , President and CEO of Hospice ... Feltman , executives with Home Health Depot, Inc., the ... This acquisition helps Hospice Cloud maintain its position ... medical equipment (DME) solutions for the hospice industry. ...
Breaking Medicine Technology: